These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22743031)

  • 1. Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature.
    Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Vacchi C; Spagnolo P; Cerri S; Luppi F; Richeldi L; Ferri C
    Autoimmun Rev; 2013 Jan; 12(3):374-9. PubMed ID: 22743031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature.
    Colaci M; Giuggioli D; Vacchi C; Lumetti F; Iachetta F; Marcheselli L; Federico M; Ferri C
    Autoimmun Rev; 2014 Feb; 13(2):132-7. PubMed ID: 24103404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.
    Kang KY; Yim HW; Kim IJ; Yoon JU; Ju JH; Kim HY; Park SH
    Scand J Rheumatol; 2009; 38(4):299-303. PubMed ID: 19308805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
    Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
    Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease.
    Wuttge DM; Wildt M; Geborek P; Wollheim FA; Scheja A; Akesson A
    Arthritis Res Ther; 2007; 9(5):R85. PubMed ID: 17784951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.
    De Luca G; Bosello SL; Berardi G; Rucco M; Canestrari G; Correra M; Mirone L; Forni F; Di Mario C; Danza FM; Pirronti T; Ferraccioli G
    Rheumatology (Oxford); 2015 Nov; 54(11):1991-9. PubMed ID: 26106211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis.
    Thompson AE; Pope JE
    J Rheumatol; 2002 Sep; 29(9):1867-73. PubMed ID: 12233880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort.
    Marangoni RG; Rocha LF; Del Rio AP; Yoshinari NH; Marques-Neto JF; Sampaio-Barros PD
    Rheumatology (Oxford); 2013 Aug; 52(8):1520-4. PubMed ID: 23661427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancies associated with systemic sclerosis.
    Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
    Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of sicca symptoms in a South Australian cohort with systemic sclerosis.
    Swaminathan S; Goldblatt F; Dugar M; Gordon TP; Roberts-Thomson PJ;
    Intern Med J; 2008 Dec; 38(12):897-903. PubMed ID: 18422567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database.
    Walker UA; Tyndall A; Czirják L; Denton CP; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 Jun; 68(6):856-62. PubMed ID: 18625615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancers in systemic sclerosis : risk factors, impact on survival and literature review].
    Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
    Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.